Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System

NCT07687485 is registered in ClinicalTrials.gov with Laplace Interventional, Inc as lead sponsor.

NCT NCT07687485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07687485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System
Lead sponsor
Laplace Interventional, Inc
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2038
Enrollment
700 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases (cvd), heart valve diseases, severe heart valve disease, severe tricuspid valve regurgitation, symptomatic tricuspid regurgitation, tricuspid valve disease, tricuspid valve insufficiency, tricuspid valve regurgitation